Federated Hermes’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.3M | Buy |
129,340
+3,500
| +3% | +$649K | 0.04% | 445 |
|
|
2025
Q4 | $25.1M | Sell |
125,840
-386
| -0.3% | -$70K | 0.04% | 402 |
|
|
2025
Q3 | $19.7M | Buy |
126,226
+160
| +0.1% | +$25.4K | 0.03% | 433 |
|
|
2025
Q2 | $19.1M | Buy |
126,066
+125,841
| +55,929% | +$16.8M | 0.04% | 440 |
|
|
2025
Q1 | $33.9K | Sell |
225
-2,172
| -91% | -$364K | ﹤0.01% | 1671 |
|
|
2024
Q4 | $442K | Sell |
2,397
-42,039
| -95% | -$8.1M | ﹤0.01% | 1348 |
|
|
2024
Q3 | $8.75M | Sell |
44,436
-4,704
| -10% | -$978K | 0.02% | 605 |
|
|
2024
Q2 | $10.2M | Sell |
49,140
-39
| -0.1% | -$8.84K | 0.02% | 552 |
|
|
2024
Q1 | $13.3M | Sell |
49,179
-25,028
| -34% | -$5.98M | 0.03% | 508 |
|
|
2023
Q4 | $17.5M | Sell |
74,207
-99
| -0.1% | -$19.5K | 0.04% | 422 |
|
|
2023
Q3 | $14.6M | Sell |
74,306
-30,066
| -29% | -$6.17M | 0.04% | 444 |
|
|
2023
Q2 | $21.9M | Sell |
104,372
-22,423
| -18% | -$4.46M | 0.05% | 358 |
|
|
2023
Q1 | $25.6M | Sell |
126,795
-23,233
| -15% | -$5.27M | 0.06% | 323 |
|
|
2022
Q4 | $32.7M | Sell |
150,028
-36,889
| -20% | -$8.06M | 0.09% | 280 |
|
|
2022
Q3 | $36.8M | Sell |
186,917
-25,951
| -12% | -$5.6M | 0.11% | 235 |
|
|
2022
Q2 | $45.5M | Buy |
212,868
+18,196
| +9% | +$4.45M | 0.12% | 213 |
|
|
2022
Q1 | $55.3M | Sell |
194,672
-19,988
| -9% | -$6.16M | 0.12% | 212 |
|
|
2021
Q4 | $80.9M | Buy |
214,660
+15,076
| +8% | +$5.86M | 0.15% | 190 |
|
|
2021
Q3 | $82.4M | Buy |
199,584
+4,811
| +2% | +$2M | 0.16% | 182 |
|
|
2021
Q2 | $72.1M | Sell |
194,773
-9,689
| -5% | -$3.24M | 0.13% | 208 |
|
|
2021
Q1 | $59.3M | Buy |
204,462
+29,137
| +17% | +$8.1M | 0.11% | 231 |
|
|
2020
Q4 | $43.8M | Sell |
175,325
-22,415
| -11% | -$5.34M | 0.09% | 280 |
|
|
2020
Q3 | $44.8M | Sell |
197,740
-15,033
| -7% | -$3.12M | 0.11% | 229 |
|
|
2020
Q2 | $37.1M | Sell |
212,773
-9,295
| -4% | -$1.48M | 0.09% | 256 |
|
|
2020
Q1 | $28M | Buy |
222,068
+48,441
| +28% | +$7.27M | 0.08% | 264 |
|
|
2019
Q4 | $26.5M | Buy |
173,627
+24,067
| +16% | +$3.33M | 0.06% | 335 |
|
|
2019
Q3 | $19.8M | Buy |
149,560
+30,931
| +26% | +$4.15M | 0.05% | 373 |
|
|
2019
Q2 | $16.8M | Buy |
118,629
+10,208
| +9% | +$1.38M | 0.04% | 395 |
|
|
2019
Q1 | $15.7M | Buy |
108,421
+74,915
| +224% | +$9.84M | 0.04% | 412 |
|
|
2018
Q4 | $3.79M | Buy |
33,506
+15,670
| +88% | +$1.96M | 0.01% | 816 |
|
|
2018
Q3 | $2.4M | Sell |
17,836
-4,247
| -19% | -$524K | 0.01% | 1026 |
|
|
2018
Q2 | $2.48M | Buy |
22,083
+3,537
| +19% | +$382K | 0.01% | 928 |
|
|
2018
Q1 | $1.98M | Sell |
18,546
-5,220
| -22% | -$563K | 0.01% | 963 |
|
|
2017
Q4 | $2.6M | Sell |
23,766
-4,236
| -15% | -$461K | 0.01% | 832 |
|
|
2017
Q3 | $3.02M | Sell |
28,002
-66,585
| -70% | -$6.84M | 0.01% | 743 |
|
|
2017
Q2 | $9.57M | Buy |
94,587
+69,352
| +275% | +$6.38M | 0.03% | 412 |
|
|
2017
Q1 | $2.27M | Sell |
25,235
-1,238
| -5% | -$105K | 0.01% | 858 |
|
|
2016
Q4 | $2.02M | Sell |
26,473
-48,884
| -65% | -$3.71M | 0.01% | 862 |
|
|
2016
Q3 | $6.28M | Sell |
75,357
-48,628
| -39% | -$4.08M | 0.02% | 515 |
|
|
2016
Q2 | $10.2M | Sell |
123,985
-3,146
| -2% | -$259K | 0.03% | 425 |
|
|
2016
Q1 | $9.65M | Buy |
127,131
+68,413
| +117% | +$5.06M | 0.03% | 418 |
|
|
2015
Q4 | $4.72M | Buy |
58,718
+32,741
| +126% | +$2.36M | 0.01% | 581 |
|
|
2015
Q3 | $1.65M | Sell |
25,977
-2,165
| -8% | -$155K | 0.01% | 936 |
|
|
2015
Q2 | $1.98M | Sell |
28,142
-430
| -2% | -$31.8K | 0.01% | 926 |
|
|
2015
Q1 | $2.27M | Buy |
28,572
+1,312
| +5% | +$96.8K | 0.01% | 920 |
|
|
2014
Q4 | $1.73M | Sell |
27,260
-11,053
| -29% | -$693K | 0.01% | 1009 |
|
|
2014
Q3 | $2.29M | Sell |
38,313
-2,070
| -5% | -$118K | 0.01% | 911 |
|
|
2014
Q2 | $2.16M | Buy |
40,383
+9,066
| +29% | +$497K | 0.01% | 929 |
|
|
2014
Q1 | $1.89M | Sell |
31,317
-574
| -2% | -$33.5K | 0.01% | 973 |
|
|
2013
Q4 | $1.69M | Sell |
31,891
-3,489
| -10% | -$175K | 0.01% | 994 |
|
|
2013
Q3 | $1.64M | Buy |
35,380
+5,254
| +17% | +$241K | 0.01% | 977 |
|
|
2013
Q2 | $1.24M | Buy |
+30,126
| New | +$1.29M | ﹤0.01% | 1050 |
|
Other funds holding CRL
VCM
VPM
Federated Hermes's CRL Position: Q1 2026 in Review
Federated Hermes increased its Charles River Laboratories (CRL) stake by 2.8% in Q1 2026, buying an estimated $649K and bringing the position to 129,340 shares worth $22.3M. The position accounts for 0.04% of the portfolio, ranked #445.
Federated Hermes first reported a position in CRL in Q2 2013 and has held it in 52 quarters since. The position peaked at $82.4M in Q3 2021. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- Federated Hermes held 129,340 shares of Charles River Laboratories worth $22.3M as of Q1 2026.
- Federated Hermes bought 3,500 Charles River Laboratories shares in Q1 2026, an estimated $649K.
- Charles River Laboratories made up 0.04% of Federated Hermes's portfolio in Q1 2026, its #445 holding.
- Federated Hermes first reported a position in Charles River Laboratories in Q2 2013 and has held it in 52 quarters since.
- Federated Hermes's Charles River Laboratories position peaked at $82.4M in Q3 2021.
- 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.